State Medicaid Policies Governing Access to Medications for Opioid Use Disorder (MOUD) and MOUD Treatment Use in a Large Sample of People Who Inject Drugs in 20 U.S. States
State Medicaid methadone coverage was strongly associated with higher odds that PWID utilized MOUD, suggesting that expanding methadone insurance coverage could improve MOUD treatment in a vulnerable population.
Authors
- Courtney R. Yarbrough (ORCID: https://orcid.org/0000-0002-4216-931X)
- Catlainn Sionéan
- Umed Ibragimov
- Janet R. Cummings (ORCID: https://orcid.org/0000-0002-3845-7853)
- Hannah L. F. Cooper (ORCID: https://orcid.org/0000-0002-0521-2438)
- Stephanie Beane
- Danielle F. Haley (ORCID: https://orcid.org/0000-0002-4281-2731)
- Sarah Landes (ORCID: https://orcid.org/0000-0003-2568-7139)
- Regine Haardörfer
- Rashunda Lewis (ORCID: https://orcid.org/0000-0003-2030-0740)
- Sabriya Linton (ORCID: https://orcid.org/0000-0003-3579-2151)
Institutions
- Boston University (US)
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Publication Details
- Journal
- Substance Use & Misuse
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1080/10826084.2024.2440365
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Ministry of Urban Development
- Centers for Disease Control and Prevention
- National Institute on Drug Abuse